# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Arthur Ashe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML013-SYN
- Date: 2026-01-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Vivian Tolliver, MD
- Calendar frame: modern shifted

## Reason for visit

Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operations. **S**

## Historical basis

- Arthur Robert Ashe Jr. was born in Richmond, Virginia, on July 10, 1943, to Mattie Cunningham Ashe and Arthur Robert Ashe Sr.; his mother died before he was seven. **D**
- On July 31, 1979, while teaching tennis to inner-city youth, Ashe had a heart attack, and he then underwent quadruple coronary artery bypass surgery in 1979. **D**
- When chest pain recurred, Ashe had a second bypass operation, a double bypass, in 1983, during which he received a blood transfusion. **D**
- In 1988 Ashe had difficulty moving his right hand and arm; a scan showed a mass in the left side of his brain, which surgeons removed, and the diagnosis was toxoplasmosis. Testing then showed that he had HIV and AIDS. **D**
- Ashe and his doctors concluded that he had almost certainly acquired HIV from a blood transfusion during his 1983 heart operation, before blood was tested for the virus. **D**
- Both of Ashe's parents had atherosclerotic heart disease at early ages. His mother died at 27 of complications from surgery, and his father had two heart attacks, at 55 and at 59. **D**

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He wants to decide for himself who learns of his HIV diagnosis, and when. **S**
- He wants to keep coaching and playing tennis without putting his heart at risk. **S**

## Strengths and supports

- Supports: married, with a young child, and close friends; has told only a few people about his HIV diagnosis **S**

## Medications and allergies

- Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium **S**
- Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intake **S**
- Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intake **S**
- Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intake **S**
- Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- July 31, 1979: Heart attack at age 36 while teaching tennis to young people, followed by quadruple coronary artery bypass surgery **D** (CLM-0002)
- 1983: Second (double) bypass operation for recurrent chest pain, with a blood transfusion **D** (CLM-0003)
- 1988: Right-arm weakness from a left-sided brain mass, removed and found to be toxoplasmosis; HIV and AIDS diagnosed, believed to have been acquired from the transfusion during the 1983 operation **D** (CLM-0004, CLM-0005)

## Procedures and immunizations

- 2016-12-13 to 2016-12-13: Coronary artery bypass grafting, four grafts, after a myocardial infarction at age 36 **S**
- 2020-06-15 to 2020-06-15: Repeat coronary artery bypass grafting, two grafts, for recurrent angina; blood transfusion given **S**
- 2025-09-08 to 2025-09-08: MRI of the head with contrast: single ring-enhancing lesion in the left frontoparietal region with surrounding edema **S**
- 2025-09-10 to 2025-09-10: Stereotactic biopsy of the left frontoparietal lesion: necrotizing inflammation with Toxoplasma gondii organisms; no lymphoma **S**
- 2026-01-12 to 2026-01-12: 12-lead electrocardiogram: sinus rhythm 72/min, old inferior Q waves, no acute ST change **S**
- 2021-05-03: Tdap vaccine **S**
- 2025-09-18: Influenza vaccine, 2025-2026 season, given in the hospital **S**
- 2026-01-12: Pneumococcal conjugate vaccine PCV20 **S**
- 2026-01-12: Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**
- 2026-01-12: Meningococcal conjugate vaccine MenACWY, dose 1 of 2 **S**

## Family history

- mother: Died at 27 of complications from surgery; atherosclerotic heart disease at an early age reported **D** (CLM-0007)
- father: Heart attacks at 55 and 59; atherosclerotic heart disease at an early age reported **D** (CLM-0007)

## Measurements

HIV-1 viral load: 42 {copies}/mL (high); CD4 count: 156 /uL (low); White cell count: 4.2 10*3/uL; Hemoglobin: 13 g/dL (low); Platelets: 198 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.9 mmol/L; Creatinine: 1.18 mg/dL; eGFR: 78 mL/min/1.73 m²; Glucose: 92 mg/dL; ALT: 30 U/L; Total cholesterol: 158 mg/dL; HDL cholesterol: 40 mg/dL; Triglycerides: 150 mg/dL (high); LDL cholesterol: 88 mg/dL; HbA1c: 5.4%; PHQ-9: 5; AUDIT-C: 1. All results are synthetic.

BP 118/74 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 72 kg; BMI 21 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, composed, and thoughtful; asks precise questions about his treatment; Mood mostly good, with worry about his family and his privacy; PHQ-9 score 5 with item 9 scored 0; no thoughts of self-harm. Functional status: Right-hand weakness at diagnosis has recovered: grip and fine finger movements equal on both sides; writes and plays without difficulty; Independent in all activities; vigorous exercise without angina or breathlessness. Physical examination is intentionally limited. **S**

## Assessment

1. HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection; status draft. **S**
2. Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy; status draft. **S**
3. Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1979 and 1983 operations; status draft. **S**
4. Old myocardial infarction at age 36; status draft. **S**
5. Hyperlipidemia, on high-intensity statin; status draft. **S**

## Plan

- Antiretroviral therapy with bictegravir, emtricitabine, and tenofovir alafenamide once daily, chosen for its high barrier to resistance and few interactions with his cardiac medicines; viral load and CD4 count every three months. Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV (current online edition); Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel (2024); Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020) **S**
- Infectious diseases consultation to co-manage HIV: the regimen and its interactions, opportunistic-infection prophylaxis, the monitoring schedule, and vaccines. Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV (current online edition); Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV: Toxoplasma gondii encephalitis and Pneumocystis pneumonia sections (current online edition) **S**
- Toxoplasma maintenance therapy with trimethoprim-sulfamethoxazole double strength twice daily, which also prevents Pneumocystis pneumonia, until the CD4 count is above 200 for more than six months on suppressive therapy; blood count, potassium, and creatinine every three months while on it. Guideline: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV: Toxoplasma gondii encephalitis and Pneumocystis pneumonia sections (current online edition) **S**
- Secondary prevention of coronary disease after two bypass operations: aspirin, high-intensity atorvastatin with ezetimibe added for an LDL goal below 55 mg/dL, blood pressure below 130/80, a heart-healthy diet, regular exercise, and a written chest-pain plan with sublingual nitroglycerin. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Vaccines for adults with HIV: pneumococcal, hepatitis B with an antibody check afterwards, the two-dose meningococcal ACWY series, recombinant zoster, and seasonal influenza and COVID-19, with no live vaccines while the CD4 count is below 200. Guideline: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020); Adult Immunization Schedule by Medical Condition and Other Indication (2026) **S**
- Person-first, confidential care: he decides who learns of his diagnosis; support with disclosure if and when he chooses, peer support, and depression screening with the PHQ-9 at intake and six months and the PHQ-2 at the preventive visit. Guideline: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**

## Guideline basis

- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV (current online edition), U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents
- Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV: Toxoplasma gondii encephalitis and Pneumocystis pneumonia sections (current online edition), National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America
- Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel (2024), International Antiviral Society-USA (JAMA)
- Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020), HIV Medicine Association of the Infectious Diseases Society of America (Clinical Infectious Diseases)
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026), Aether Forge
